EUVIMEDEUVIMED entdecken
Vergleichsstudie

Effects of intranasal antihistaminic and corticosteroid therapies on olfactory dysfunction in adults with perennial allergic rhinitis: a prospective comparative study

Ayşe Enise Göker, Elif Aksungur, Cem Çelik, Uğur Uygan, Gülpembe Bozkurt, Ayça Başkadem Yılmazer, Maide Hacer Alagöz

European Archives of Oto-Rhino-Laryngology · 2026-10 · 283 (11) · 7241-7249

DOI: 10.1007/s00405-026-10574-5 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 26.08.2026. Verfasst von Ayşe Enise Göker und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, University of Health Sciences, Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Phthalazines, Mometasone Furoate, Rhinitis, Allergic, Perennial, Anti-Allergic Agents. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To compare the effects of commonly used intranasal therapies on olfactory dysfunction in adults with perennial allergic rhinitis using objective psychophysical testing. METHODS: This prospective study included 90 adults with perennial allergic rhinitis and objectively confirmed hyposmia. Patients were allocated into three treatment groups: intranasal azelastine monotherapy, intranasal azelastine plus mometasone furoate combination therapy, and intranasal mometasone furoate monotherapy. Treatments were administered for one month. Olfactory function was assessed before and after treatment using the Sniffin' Sticks test (threshold, discrimination, identification, and composite TDI score). Nasal obstruction was evaluated using the Nasal Obstruction Symptom Evaluation (NOSE) scale. Between-group comparisons of treatment-related change scores and supportive within-group analyses were performed using non-parametric statistical tests. RESULTS: Ninety patients were included, with 30 patients in each treatment group. The mean ages were 29.43 ± 10.58 years in the azelastine group, 29.13 ± 8.79 years in the azelastine plus mometasone furoate group, and 29.90 ± 6.33 years in the mometasone furoate group. Baseline TDI scores were 29.10 ± 1.45, 28.37 ± 2.83, and 27.70 ± 2.34, respectively. Mean ΔTDI was - 3.33 ± 4.14 in the azelastine group, 9.13 ± 4.35 in the combination group, and 11.90 ± 3.82 in the mometasone furoate group, with a significant between-group difference (p < 0.001). CONCLUSION: In adults with perennial allergic rhinitis and objectively confirmed hyposmia, intranasal corticosteroid-containing regimens were associated with greater improvement in olfactory function than azelastine monotherapy. These findings suggest that intranasal corticosteroid-containing regimens may be preferable when olfactory dysfunction accompanies perennial allergic rhinitis. However, given the non-randomized and open-label design of the study, the results should be interpreted with caution.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhthalazinesMometasone FuroateRhinitis, Allergic, PerennialAnti-Allergic AgentsOlfaction DisordersHistamine AntagonistsAdrenal Cortex HormonesHumansAdultFemaleMaleProspective StudiesAdministration, IntranasalDrug Therapy, CombinationTreatment OutcomeYoung AdultMiddle Aged

Stichwörter der Autor:innen

Allergic rhinitisHyposmiaIntranasal antihistaminesIntranasal corticosteroidsOlfactory dysfunctionSniffin’ Sticks

Substanzen

PhthalazinesazelastineMometasone FuroateAnti-Allergic AgentsHistamine AntagonistsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, University of Health Sciences, Prof. Dr. Cemil Taşcıoğlu City Hospital, İstanbul, Türkiye.
  • Department of Otorhinolaryngology, Pendik Yüzyıl Hospital, İstanbul, Türkiye.
  • Department of Otorhinolaryngology, Gaziantep City Hospital, Gaziantep, Türkiye. ceemcelik1@gmail.com.
  • Department of Otorhinolaryngology, Hakkari State Hospital, Hakkari, Türkiye.
  • Department of Biochemistry, University of Health Sciences, Kartal Dr. Lütfi Kırdar City Hospital, İstanbul, Türkiye.

Zitieren

APA

Göker, A. E., Aksungur, E., Çelik, C., Uygan, U., Bozkurt, G., Yılmazer, A. B., & Alagöz, M. H. (2026). Effects of intranasal antihistaminic and corticosteroid therapies on olfactory dysfunction in adults with perennial allergic rhinitis: a prospective comparative study. European Archives of Oto-Rhino-Laryngology, 283(11), 7241-7249. https://doi.org/10.1007/s00405-026-10574-5

Vancouver

Göker AE, Aksungur E, Çelik C, Uygan U, Bozkurt G, Yılmazer AB, et al. Effects of intranasal antihistaminic and corticosteroid therapies on olfactory dysfunction in adults with perennial allergic rhinitis: a prospective comparative study. European Archives of Oto-Rhino-Laryngology. 2026;283(11):7241-7249. doi:10.1007/s00405-026-10574-5

BibTeX
@article{Gker2026,
  author = {Göker, Ayşe Enise and Aksungur, Elif and Çelik, Cem and Uygan, Uğur and Bozkurt, Gülpembe and Yılmazer, Ayça Başkadem and Alagöz, Maide Hacer},
  title = {Effects of intranasal antihistaminic and corticosteroid therapies on olfactory dysfunction in adults with perennial allergic rhinitis: a prospective comparative study},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2026},
  volume = {283},
  number = {11},
  pages = {7241--7249},
  doi = {10.1007/s00405-026-10574-5}
}
Kostenlos starten →